These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7528626)

  • 1. Cytomegalovirus infection in living related liver transplantation: rapid diagnosis by human monoclonal antibody staining of blood leucocytes.
    Sano K; Tanaka K; Uemoto S; Fujita S; Tokunaga Y; Inomata Y; Ozawa K; Minamishima Y
    Transplant Sci; 1994 Sep; 4(1):105-11. PubMed ID: 7528626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
    Freymuth F; Petitjean J; Eugene-Ruelland G; Daon F; Galateau F
    Pathol Biol (Paris); 1993 Oct; 41(8):724-30. PubMed ID: 8290319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapid diagnosis of cytomegalovirus hepatitis after liver transplantation. Use of monoclonal antibody E13 directed against an early viral antigen].
    Spatz A; Tricottet V; Saliba F; Samuel D; Bismuth H; Reynès M
    Ann Pathol; 1990; 10(5-6):331-5. PubMed ID: 1964784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytomegalovirus antigenemia in the differential diagnosis of pulmonary infiltrates after allogeneic bone marrow transplantation].
    Gondo H; Harada M; Minematsu T; Akashi K; Hayashi S; Taniguchi S; Yamasaki K; Shibuya T; Takamatsu Y; Eto T
    Rinsho Ketsueki; 1993 Nov; 34(11):1438-44. PubMed ID: 8254905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.
    Kanda Y; Mineishi S; Saito T; Seo S; Saito A; Suenaga K; Ohnishi M; Niiya H; Nakai K; Takeuchi T; Kawahigashi N; Shoji N; Ogasawara T; Tanosaki R; Kobayashi Y; Tobinai K; Kami M; Mori S; Suzuki R; Kunitoh H; Takaue Y
    Bone Marrow Transplant; 2001 Feb; 27(4):437-44. PubMed ID: 11313674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
    Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus antigenemia.
    The TH; van der Bij W; van den Berg AP; van der Giessen M; Weits J; Sprenger HG; van Son WJ
    Rev Infect Dis; 1990; 12 Suppl 7():S734-44. PubMed ID: 2173103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
    Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
    Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation.
    Steinhoff G; Behrend M; Wagner TO; Höper MH; Haverich A
    J Heart Lung Transplant; 1991; 10(1 Pt 1):9-14. PubMed ID: 1848789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation.
    Härmä M; Höckerstedt K; Lyytikäinen O; Lautenschlager I
    J Med Virol; 2006 Jun; 78(6):800-5. PubMed ID: 16628583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
    Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
    Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation.
    Gondo H; Minematsu T; Harada M; Akashi K; Hayashi S; Taniguchi S; Yamasaki K; Shibuya T; Takamatsu Y; Teshima T
    Br J Haematol; 1994 Jan; 86(1):130-7. PubMed ID: 8011521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.
    Lautenschlager I; Höckerstedt K; Salmela K
    Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients.
    van der Bij W; van Dijk RB; van Son WJ; Torensma R; Prenger KB; Prop J; Tegzess AM; The TH
    J Heart Transplant; 1988; 7(2):106-9. PubMed ID: 2835469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.